Medication Selection and Nursing Interventions for Parkinson’s Disease Patients

© 2024 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

HTML

Abstract

Parkinson’s disease is a neurodegenerative disorder that significantly impacts patients’ lives. Currently, treatment primarily relies on drug therapy, while effective nursing interventions can help mitigate adverse reactions associated with medication use. This article reviews medication selection and nursing interventions for patients with Parkinson’s disease, aiming to alleviate symptoms, improve quality of life, and provide a scientific and comprehensive basis for medication and clinical nursing practices.

References

Liu X, 2021, Electroacupuncture Retards the Progression of Alzheimer’s Disease by Regulating Cell Autophagy, Glucose Metabolism, and Ferroptosis Through Long Non-Coding RNA SNHG1 and Its Mechanism, dissertation, Nanchang University.

Lin P, Liang J, Guan Y, et al., 2023, Research Progress on the Mechanism of Traditional Chinese Medicine in Prevention and Treatment of Parkinson’s Disease. Guangxi Traditional Chinese Medicine, 46(4): 71–74.

Zhen J, Zheng X, Wu J, 2020, Research Progress of Human Induced Pluripotent Stem Cells in the Treatment of Parkinson’s Disease. Journal of Stroke and Neurological Disease, 37(1): 84–86.

Liu Y, Ma K, 2021, Progress of Drug Therapy in Different Stages of Parkinson’s Disease. Chinese Medicine Review, 40(6): 758–764.

Wang X, 2022, Effects of Daidzein on Neuroinflammation and Oxidative Stress and Its Mechanism, dissertation, Hefei University of Technology.

Pang W, Zhai L, Liu Y, et al., 2021, Analysis of Global Guidelines for Comprehensive Treatment of Parkinson’s Disease. Chinese Journal of Clinical Pharmacology, 38(21): 2638–2643.

Sun J, Xiong H, Yao Y, 2020, Advances in the Treatment of Parkinson’s Disease. Medical Review, 26(6): 1157–1160 + 1165.

Chen F, 2020, Current Status and Progress of Diagnosis and Treatment of Parkinson’s Disease. Medical Information, 33(12): 43–46.

Sun W, Bi H, 2021, Research Progress of Parkinson’s Disease in Traditional Chinese and Western Medicine. Modern Journal of Integrated Traditional Chinese and Western Medicine, 31(16): 2321–2325.

Zhang C, Zhang H, Qu C, et al., 2014, Bushen Tongluo Capsule Combined with Madopar in the Treatment of Advanced Parkinson’s Disease: A Clinical Study. Chinese Patent Materia Medica, 36(2): 263–265.

Wang R, 2013, Nursing Experience of Patients with Parkinson’s Disease. Guangming Traditional Chinese Medicine, 28(9): 1924–1925.

Gao G, 2004, The Key Points in the Diagnosis and Treatment of Parkinson’s Disease. Jiangsu Science and Technology Press, Nanjing, 267.

Liu C, Huang X, 2018, Research on the Academic Origin and Development of the Etiology, Pathogenesis, and Treatment Principles of Parkinson’s Disease. Beijing Traditional Chinese Medicine, 37(8): 780–784.

Li H, Wang H, Bian C, et al., 2002, Nursing Experience of Elderly Patients with Parkinson’s Disease. Journal of Chengde Medical College, 19(4): 299.

Luo X, Li Z, Zhu M, et al., 2021, Expert Consensus on Clinical Diagnosis and Treatment of Parkinson’s Disease with Traditional Chinese Medicine. Chinese Journal of Medicine, 62(23): 2109–2116.

Previous article in this issue

Next article in this issue